Prostaglandin levels in cerebrospinal fluid from multiple sclerosis patients in remission and relapse
Authors:
- Christopher BoltonCBChristopher Bolton
- Alan M. TurnerATAlan M. Turner
- John L. TurkJTJohn L. Turk
- 1 June 1984
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 6 (3) , 151-159
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic LesionsScience, 1983
- Bradykinin-stimulated prostaglandin E2 production by endothelial cells and its modulation by antiinflammatory compoundsInflammation, 1981
- The significance of abnormal immune responses in patients with multiple sclerosisJournal of Neuroimmunology, 1981
- A comparison of the quantitative analysis of 6-oxo-PGF1α in biological fluids by gas chromatography mass spectrometry and radioimmunoassayJournal of Mass Spectrometry, 1981
- Immunosuppressive drugs in multiple sclerosisNeurology, 1980
- The scientific basis of multiple sclerosisMolecular Aspects of Medicine, 1979
- Prostaglandins and chronic inflammationBiochemical Pharmacology, 1978
- Prostaglandins and the immune responseLife Sciences, 1977
- Determination of prostaglandin F2α and E2 contents in human cerebrospinal fluid by the radioisotope dilution methodProstaglandins, 1976
- Studies on the Pathogenesis of Multiple SclerosisEuropean Neurology, 1973